ClinicalTrials.Veeva

Menu

Women's Quality of Life, Sexual Life and Psychological State in Patients Undergoing Embryo Transfers

B

Bahceci Health Group

Status

Unknown

Conditions

Sexual Function and Fertility Disorders
Quality of Life
Depression
Infertility, Female
Anxiety State

Treatments

Other: Filling out the forms including IDAS-II, BAI, SF-36 and FSFI

Study type

Observational

Funder types

Other

Identifiers

NCT04131452
Bahceci Mehmet Asoglu

Details and patient eligibility

About

Women's quality of life, sexual life and psychological state would affect the success of embryo transfer. The primary purpose of the study is to compare women's quality of life, sexual life and psychological state using validated forms between those undergoing fresh embryo transfer and those undergoing frozen embryo transfer.

Full description

There are two types of embryo transfers; fresh and frozen embryo transfers. Studies have been conducted to compare success rates between fresh and frozen embryo transfers. However, most studies have not taken into consideration women's quality of life, sexual life and psychological state in comparing fresh embryo transfer with frozen embryo transfers. These all parameters are confounding factors that may influence the success of embryo transfer. The purpose of this study is to compare women's quality of life, sexual life and psychological state using validated forms between those undergoing fresh embryo transfer and those undergoing frozen embryo transfer. The following forms will be used: expanded version of the inventory of depression and anxiety symptoms (IDAS-II), Beck Anxiety inventory (BAI), Short Form Survey (SF-36) and Female Sexual Function Index (FSFI. This study can provide evidence regarding the association between women's quality of life, sexual life and psychological state and embryo transfer success.

Enrollment

232 estimated patients

Sex

Female

Ages

20 to 39 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 20 - 39 years
  • Body mass index between 18 -3 5 kg/m2
  • Anti-mullerian hormone levele >1.1 ng/ml or antral follicle count > 8
  • fresh or frozen embryo transfer using middle-quality or good-quality day 3 or 5 embryos

Exclusion criteria

  • Age below 20 or over 39 years
  • Uterine malformations
  • Hypo or hyperthyroidism
  • Diabetes mellitus
  • Previous history of psychiatric disorders
  • Use of psychiatric medications
  • Systemic disorders (hypertension, chronic liver/kidney/heart problems)

Trial design

232 participants in 2 patient groups

Fresh embryo transfers
Description:
those undergoing fresh embryo transfer
Treatment:
Other: Filling out the forms including IDAS-II, BAI, SF-36 and FSFI
Frozen embryo transfers
Description:
those undergoing frozen embriyo transfer
Treatment:
Other: Filling out the forms including IDAS-II, BAI, SF-36 and FSFI

Trial contacts and locations

1

Loading...

Central trial contact

Cem Celik, Prof; Mehmet Resit Asoglu, Ass. Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems